LENSAR (LNSR) Competitors $12.06 -0.08 (-0.66%) Closing price 04:00 PM EasternExtended Trading$12.10 +0.04 (+0.37%) As of 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LNSR vs. AVNS, ZIMV, KIDS, TMCI, SMLR, CBLL, BFLY, CARL, RXST, and DCTHShould you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Avanos Medical (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Butterfly Network (BFLY), Carlsmed (CARL), RxSight (RXST), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. LENSAR vs. Its Competitors Avanos Medical ZimVie OrthoPediatrics Treace Medical Concepts Semler Scientific CeriBell Butterfly Network Carlsmed RxSight Delcath Systems Avanos Medical (NYSE:AVNS) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment. Which has preferable valuation & earnings, AVNS or LNSR? LENSAR has lower revenue, but higher earnings than Avanos Medical. LENSAR is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvanos Medical$692.50M0.77-$392.10M-$10.07-1.15LENSAR$58.36M2.47-$31.40M-$4.21-2.86 Which has more risk & volatility, AVNS or LNSR? Avanos Medical has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500. Is AVNS or LNSR more profitable? Avanos Medical has a net margin of -66.89% compared to LENSAR's net margin of -84.49%. Avanos Medical's return on equity of 6.16% beat LENSAR's return on equity.Company Net Margins Return on Equity Return on Assets Avanos Medical-66.89% 6.16% 4.57% LENSAR -84.49%-737.30%-72.60% Do analysts prefer AVNS or LNSR? LENSAR has a consensus target price of $15.00, suggesting a potential upside of 24.38%. Given LENSAR's higher possible upside, analysts plainly believe LENSAR is more favorable than Avanos Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avanos Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00LENSAR 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media refer more to AVNS or LNSR? In the previous week, Avanos Medical had 1 more articles in the media than LENSAR. MarketBeat recorded 3 mentions for Avanos Medical and 2 mentions for LENSAR. Avanos Medical's average media sentiment score of 1.24 beat LENSAR's score of 0.95 indicating that Avanos Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avanos Medical 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LENSAR 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of AVNS or LNSR? 95.2% of Avanos Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 2.6% of Avanos Medical shares are owned by insiders. Comparatively, 38.5% of LENSAR shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryAvanos Medical beats LENSAR on 9 of the 14 factors compared between the two stocks. Get LENSAR News Delivered to You Automatically Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LNSR vs. The Competition Export to ExcelMetricLENSARMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$143.94M$6.51B$5.65B$10.29BDividend YieldN/A1.20%5.68%4.62%P/E Ratio-2.8625.0375.8426.11Price / Sales2.47197.54517.46171.25Price / CashN/A21.7937.5661.52Price / Book28.715.0112.876.30Net Income-$31.40M$178.07M$3.29B$271.03M7 Day Performance-2.74%-1.26%-0.26%-0.15%1 Month Performance-4.74%6.15%3.84%6.41%1 Year Performance172.23%22.81%68.35%28.81% LENSAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNSRLENSAR1.5386 of 5 stars$12.06-0.7%$15.00+24.4%+174.7%$143.94M$58.36M-2.86110Positive NewsAVNSAvanos Medical1.7904 of 5 stars$12.28+0.5%N/A-49.0%$567.03M$692.50M-1.222,227Positive NewsZIMVZimVie1.2775 of 5 stars$18.89+0.1%$17.75-6.0%+18.9%$532.34M$449.75M-26.991,770Positive NewsKIDSOrthoPediatrics4.4061 of 5 stars$19.56-0.5%$34.14+74.6%-30.5%$492.70M$204.73M-10.93200Positive NewsTMCITreace Medical Concepts2.3451 of 5 stars$7.22flat$9.83+36.2%+24.9%$456.11M$209.36M-9.14250SMLRSemler Scientific2.8391 of 5 stars$28.39-2.7%$81.75+188.0%+38.6%$432.16M$42.98M11.68120Trending NewsAnalyst ForecastGap DownCBLLCeriBell2.0715 of 5 stars$11.95+3.3%$32.14+169.0%N/A$424.20M$65.44M-4.00N/ABFLYButterfly Network3.2682 of 5 stars$1.66+5.4%$3.00+81.3%+26.5%$395.23M$82.06M-5.91460Gap UpCARLCarlsmedN/A$14.65-0.9%N/AN/A$393.14M$27.17M0.00100Positive NewsRXSTRxSight1.6185 of 5 stars$9.23-0.9%$10.00+8.3%-81.2%$380.93M$139.93M-11.54220DCTHDelcath Systems2.566 of 5 stars$10.67-1.6%$24.50+129.6%+23.4%$379.19M$70.24M213.4060Positive News Related Companies and Tools Related Companies Avanos Medical Competitors ZimVie Competitors OrthoPediatrics Competitors Treace Medical Concepts Competitors Semler Scientific Competitors CeriBell Competitors Butterfly Network Competitors Carlsmed Competitors RxSight Competitors Delcath Systems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LNSR) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LNSR Stock Alerts